COMMUNIQUÉS West-GlobeNewswire

Beacon Behavioral Partners Expands National Footprint with First Georgia Partnership
04/08/2026
Physician-led partnership deepens access to behavioral healthcare through partnership with AR Psychiatric & Counseling Center Georgia and strengthens its growing behavioral health network across the nation PLANO, [...]
Carbonium Core Reports Rare Earth and Critical Mineral Content in Initial Sample Assay
04/08/2026
Multi-element analysis returns elevated concentrations of both light and heavy rare earth elements, along with a broad suite of industrial metals FREDERICK, Md., Aug. 04, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental [...]
Corbus Pharmaceuticals Announces Last Patient Last Visit in CANYON-1 Study of CRB-913 for the Treatment of Obesity
04/08/2026
Dose-finding Phase 1b study (n=240) on track for topline data in September 2026 CANYON-1 follows promising data from Phase 1a SAD/MAD study that demonstrated differentiated GI tolerability from GLP-1 class CRB-913 [...]
RenovoRx to Highlight TAMP™ Platform at JonesTrading Virtual Key Opinion Leader Webinar on the Evolving Pancreatic Cancer Landscape, August 13th
04/08/2026
MOUNTAIN VIEW, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (“RenovoRx” or “the Company”) ( Nasdaq: RNXT ), a life sciences company developing innovative targeted oncology therapies and commercializing [...]
Milestone Scientific Announces Strategic Federal Distribution Partnership with Red One Medical to Expand Commercial Access for the CompuFlo® Epidural System
04/08/2026
Partnership Expands Commercial Reach Across VA, Department of Defense and Other Federal Healthcare Systems ROSELAND, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a medical [...]
Entera Bio Phase 2 Data Supporting EB613’s (Oral PTH(1-34)) Anabolic Effect on Postmenopausal Women with Osteoporosis at High Risk for Fracture Selected for Plenary Poster Session Presentation at the ASBMR 2026 Annual Meeting
04/08/2026
TEL AVIV, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced that post-hoc data from its Phase 2 clinical trial of [...]
Veru Announces Notice of Allowance for Key Methods of Use U.S. Patent for Enobosarm in Combination with Semaglutide for Quality Weight Loss
04/08/2026
-- When issued U.S. patent protection until at least October 2044 -- -- Allowed patent adds to already issued enobosarm specific molecule polymorph composition of matter patents, as well as number of other pending [...]
Sofwave Medical Reports Second Quarter and First Half 2026 Financial Results and Business Highlights
04/08/2026
Second quarter revenue of $30M, +43% year-over-year growth; IFRS gross margin of 76.5% Second quarter usage fee revenue of $13.9M, 52.2% year-over-year growth First half revenue of $54.4M, +44% year-over-year growth; [...]
Bicara Therapeutics to Report Second Quarter 2026 Financial Results and Business Updates on August 11, 2026, at 8:30 AM ET
04/08/2026
BOSTON, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]
Wave Life Sciences to Present at Upcoming Investor Conferences
04/08/2026
CAMBRIDGE, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]
Allogene Therapeutics to Report Second Quarter 2026 Financial Results and Provide Business Update
04/08/2026
Conference Call and Webcast Scheduled for August 12, 2026 at 2:00 p.m. PT/5:00 p.m. ET SOUTH SAN FRANCISCO, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage [...]
Cannabix Targets Combat Sports Market for Commercial Rollout of Marijuana Breath Test at ABC Boxing & MMA Conference
04/08/2026
VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”), a developer of marijuana and alcohol breath testing [...]
Amplia Signs Collaboration Agreement With Lilly, Evaluating Narmafotinib Plus Lilly’s Kras G12C Inhibitor, Olomorasib, in Non-small Cell Lung Cancer
04/08/2026
HIGHLIGHTS Amplia has executed a Clinical Trial Collaboration & Supply Agreement (CTCSA) with Eli Lilly & Company, to evaluate the Company’s investigational FAK inhibitor narmafotinib in combination with Lilly’s [...]
Akari Therapeutics Releases CEO Corner Highlighting Strategic WhiteHawk Collaboration and the Expanding Opportunity for Dual-Payload ADC Innovation
04/08/2026
Discussion explores how combining complementary payload technologies may unlock new therapeutic opportunities while reinforcing the versatility of Akari's proprietary PH1 spliceosome-modulating payload platform Access [...]
Integrity Urgent Care Clinic Opens in Conroe, Texas
04/08/2026
Conroe’s newest urgent care clinic offers accessible, high-quality health care you can count on Key facts of this press release: Integrity Urgent Care opened a clinic in Conroe, Texas, on Aug. 3, 2026 New Conroe clinic [...]
Integrity Urgent Care Clinic Opens in Murphy, Texas
04/08/2026
Murphy’s newest urgent care clinic offers accessible, high-quality health care you can count on Key facts of this press release: Integrity Urgent Care opened a clinic in Murphy, Texas, on Aug. 3, 2026 New Murphy clinic [...]
Capra Biosciences Advances Domestic Manufacturing of Essential Medicines with Continued HHS Support
04/08/2026
Follow-on investment builds on prior work to advance seven pharmaceutical ingredients toward commercial-scale domestic production STERLING, Va., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Capra Biosciences, Inc., a [...]
RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties
04/08/2026
Glen Rock, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and revolutionary treatments to combat diseases [...]
H1 Partners with Novo Nordisk to Scale AI-Driven Clinical Development
04/08/2026
Partnership builds on Novo Nordisk’s AI and digital foundation to enhance clinical trial design and execution through AI-enabled workflows and insights NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- H1 today announced a [...]

Pages